Crinetics Pharmaceuticals Inc (CRNX)
43.83
-0.37
(-0.84%)
USD |
NASDAQ |
Jul 05, 16:00
43.83
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Research and Development Expense (TTM): 183.40M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 183.40M |
| December 31, 2023 | 168.53M |
| September 30, 2023 | 159.94M |
| June 30, 2023 | 148.09M |
| March 31, 2023 | 140.44M |
| December 31, 2022 | 130.22M |
| September 30, 2022 | 117.84M |
| June 30, 2022 | 107.43M |
| March 31, 2022 | 94.92M |
| December 31, 2021 | 84.26M |
| September 30, 2021 | 76.48M |
| June 30, 2021 | 68.60M |
| March 31, 2021 | 60.72M |
| Date | Value |
|---|---|
| December 31, 2020 | 57.00M |
| September 30, 2020 | 52.31M |
| June 30, 2020 | 50.44M |
| March 31, 2020 | 48.11M |
| December 31, 2019 | 41.51M |
| September 30, 2019 | 37.01M |
| June 30, 2019 | 32.08M |
| March 31, 2019 | 27.01M |
| December 31, 2018 | 24.48M |
| September 30, 2018 | 19.39M |
| June 30, 2018 | 15.03M |
| March 31, 2018 | 11.89M |
| December 31, 2017 | 9.233M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
37.01M
Minimum
Sep 2019
183.40M
Maximum
Mar 2024
96.17M
Average
84.26M
Median
Dec 2021
Research and Development Expense (TTM) Benchmarks
| Syndax Pharmaceuticals Inc | 185.47M |
| NovaBay Pharmaceuticals Inc | 0.061M |
| Palatin Technologies Inc | 25.13M |
| iBio Inc | 6.401M |
| Theriva Biologics Inc | 14.79M |